- Strong Dollar, Weak Performance: Big Pharma Is An Industry Adrift
- Trade deal seeks to empower firms to challenge governments
- Commission Names Products That Won't Need EU 'Safety Feature'
- Pharma sounds alarm over Grexit threats
- PROFILE: Vas Narasimhan on many Novartis roles, extinction fears and Hilleman influences
- Profile: Fred Hassan, pharma titan, gooseberry picker and secret geography geek